Skip to main content

Eden Research reports strong sales recovery for 2022, with significant opportunities still ahead

Eden Research CEO Sean Smith tells Proactive's Stephen Gunnion a strong recovery in the European wine grape market has boosted demand for the company's plant-derived biofungicide Mevalone as farmers return to pre-pandemic levels of pesticide applications.

Smith discussed the company's result for the year to December 31, 2022, as well as the factors that are likely to support growth in 2023, including regulatory approval for products in the US and new product lines that are nearing commercialisation. He said the commercial launch of products in the US presents a substantial opportunity.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.50
+5.35 (2.66%)
AAPL  265.65
+1.77 (0.67%)
AMD  201.92
-1.16 (-0.57%)
BAC  53.48
+0.73 (1.39%)
GOOG  303.96
+1.14 (0.38%)
META  640.46
+1.17 (0.18%)
MSFT  401.22
+4.36 (1.10%)
NVDA  189.37
+4.40 (2.38%)
ORCL  155.95
+1.98 (1.29%)
TSLA  413.94
+3.31 (0.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.